Di Biagio, Anna
 Distribuzione geografica
Continente #
NA - Nord America 167
EU - Europa 142
AS - Asia 61
SA - Sud America 17
AF - Africa 5
Totale 392
Nazione #
US - Stati Uniti d'America 166
SE - Svezia 39
IT - Italia 30
SG - Singapore 30
FR - Francia 20
CN - Cina 16
DE - Germania 16
BR - Brasile 15
FI - Finlandia 10
IE - Irlanda 7
ID - Indonesia 6
LT - Lituania 4
GB - Regno Unito 3
AT - Austria 2
BD - Bangladesh 2
IN - India 2
MA - Marocco 2
NL - Olanda 2
RU - Federazione Russa 2
TN - Tunisia 2
AR - Argentina 1
BE - Belgio 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EC - Ecuador 1
IQ - Iraq 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
MX - Messico 1
PL - Polonia 1
RS - Serbia 1
UA - Ucraina 1
Totale 392
Città #
Chandler 47
Singapore 23
Rome 15
New York 13
Ashburn 11
Milan 8
Chicago 7
Dublin 7
Wilmington 7
Jakarta 6
San Mateo 6
Bremen 5
Princeton 5
Turku 5
Boston 4
Falls Church 4
Helsinki 4
Marseille 4
Tavagnacco 4
Düsseldorf 3
Hefei 3
Lauterbourg 3
Los Angeles 3
Munich 3
São Paulo 3
Vilnius 3
Dhaka 2
Portsmouth 2
The Dalles 2
Abidjan 1
Agadir 1
Alvorada 1
Andover 1
Atlanta 1
Augusta 1
Berlin 1
Betim 1
Bishkek 1
Boardman 1
Brno 1
Brooklyn 1
Brussels 1
Buenos Aires 1
Cabo Frio 1
Cachoeiras de Macacu 1
Cantagalo 1
Castanhal 1
Charlotte 1
Ciudad Obregón 1
Council Bluffs 1
Des Moines 1
Dongguan 1
Erbil 1
Fairfield 1
Falkenstein 1
Frankfurt am Main 1
Greenlawn 1
Guangzhou 1
Hyderabad 1
Ibaiti 1
Kish 1
Krasnodar 1
Lajeado 1
Lappeenranta 1
Lebon Régis 1
Lviv 1
Miami 1
Modesto 1
Moscow 1
Nabeul 1
North Bergen 1
Norwalk 1
Nuremberg 1
Pedro Carbo 1
Phnom Penh 1
Pisa 1
Praia Grande 1
Raleigh 1
Salvador 1
Santa Clara 1
Seattle 1
Seoul 1
Taquara 1
Tianjin 1
Toledo 1
Tunis 1
Washington 1
Winter Garden 1
Wroclaw 1
Zurich 1
Totale 273
Nome #
An explainable model of host genetic interactions linked to COVID-19 severity 76
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 72
Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort 69
Simplification to atazanavir/ritonavir monotherapy for HIV-1 treated individuals on virological suppression: 48-week efficacy and safety results 58
Marked decrease in acquired resistance to antiretrovirals in latest years in Italy 57
Integrase Inhibitors Use and Cytomegalovirus Infection Predict Immune Recovery in People Living With HIV Starting First-Line Therapy 44
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 28
Totale 404
Categoria #
all - tutte 2.408
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.408


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 0 0 2 1 0 0
2021/202247 1 0 0 2 2 1 12 10 2 1 9 7
2022/2023134 19 18 7 20 7 13 6 6 13 24 1 0
2023/202460 2 18 2 4 3 17 1 2 0 1 3 7
2024/2025158 1 1 10 6 15 11 10 10 19 22 35 18
Totale 404